KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Account Payables: 2009-2025

Historic Change in Account Payables for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $7.1 million.

  • Idexx Laboratories' Change in Account Payables rose 590.45% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $762,000, marking a year-over-year decrease of 91.13%. This contributed to the annual value of $8.1 million for FY2024, which is 1551.71% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Change in Account Payables is $7.1 million, which was up 278.85% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Change in Account Payables peaked at $10.6 million during Q4 2021, and registered a low of -$8.1 million during Q1 2025.
  • Its 3-year average for Change in Account Payables is $232,000, with a median of -$1.5 million in 2024.
  • Its Change in Account Payables has fluctuated over the past 5 years, first soared by 2,159.28% in 2021, then tumbled by 301.11% in 2022.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Change in Account Payables stood at $10.6 million in 2021, then slumped by 30.19% to $7.4 million in 2022, then decreased by 15.61% to $6.2 million in 2023, then dropped by 8.06% to $5.7 million in 2024, then surged by 590.45% to $7.1 million in 2025.
  • Its Change in Account Payables was $7.1 million in Q3 2025, compared to -$4.0 million in Q2 2025 and -$8.1 million in Q1 2025.